At a glance
ClinicalIndex Comparison RecordN/ACompleted· 136 enrolled
Drug / intervention
ACUVUE® OASYS 1-DAY +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology
In Brief
A clinical study evaluating ACUVUE® OASYS 1-DAY for Visual Acuity. Completed, enrolled 136 participants across 7 sites.
Detailed Summary
This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartAug 2020
First PostedAug 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedAug 28, 2020
Enrollment StartAug 5, 2020
Primary CompletionSep 25, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.8 years ago
Interventions
ACUVUE® OASYS 1-DAYdevice
senofilcon A contact lenses made with a novel manufacturing technology
ACUVUE® OASYS 1-DAYdevice
senofilcon A contact lenses made with the current manufacturing technology